🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study aims to investigate the safety and immunogenicity of one dose vs ...
Status
Not Yet Recruiting
Location
Health Index Multispecialty Clinic, Barangay Toclong 2B
Start Date
2025-09-01
Trial ID
NCT05633446
This research will study safety and the body's immune (defense system) resp...
Status
Completed
Location
Emory Children's Center - Pediatric Infectious Diseases
Start Date
2010-06
Trial ID
NCT00912496
Treatments Being Tested
In this trial, we are evaluating the safety and tolerability of a new inves...
Status
Completed
Location
Scientia Clinical Research
Start Date
2021-06-21
Trial ID
NCT04742842
A two-part study of PRO-203 administered subcutaneously in healthy adult vo...
Status
Recruiting
Location
Nucleus Network
Start Date
2025-10-27
Trial ID
NCT07641634
This is a phase 1, randomized regimen optimization study of PfSPZ Vaccine i...
Status
Completed
Location
Baney Clinical Research Center
Start Date
2018-07-30
Trial ID
NCT03590340
Treatments Being Tested
This is a multi-center, randomized, two stage, double-blind, placebo-contro...
Status
Completed
Location
Clinical Research Center, Hadassah Medical Center
Start Date
2010-07
Trial ID
NCT01146119
Treatments Being Tested
To assess the long-term efficacy and safety of the subjects during the thir...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-02-12
Trial ID
NCT00420316
Treatments Being Tested
Randomized, double-blind, placebo-controlled trial to evaluate safety and i...
Status
Unknown
Location
Multiple Locations
Start Date
2022-03-08
Trial ID
NCT05248373
Treatments Being Tested
To confirm the efficacy and safety of rituximab (genetical recombination) i...
Status
Active Not Recruiting
Location
Anjo Kosei Hospital
Start Date
2023-06-24
Trial ID
NCT05914155
Treatments Being Tested
This is a Phase 2, randomized, placebo-controlled, and observer-blind study...
Status
Terminated
Location
Arcturus Investigational Site 103
Start Date
2021-01-07
Trial ID
NCT04668339